新型冠状病毒肺炎中的肝损伤：已知与未知
Liver injury in COVID-19: Known and unknown.
作者信息
Zhou Feng, Xia Jian, Yuan Hai-Xia, Sun Ying, Zhang Ying
机构信息
Department of Endocrinology, Puren Hospital of Wuhan University of Science and Technology, Wuhan 430080, Hubei Province, China.
Department of Critical Care Medicine, Zhongnan Hospital of Wuhan University, Wuhan 430071, Hubei Province, China.
出版信息
World J Clin Cases. 2021 Jul 6;9(19):4980-4989. doi: 10.12998/wjcc.v9.i19.4980.
Abstract
Since the first report of the coronavirus disease 2019 (COVID-19) in December 2019 in Wuhan, China, the outbreak of the disease is currently continuously evolving. Previous studies have shown varying degrees of liver damage in patients with COVID-19. However, the exact causes of liver injury and the relationship between COVID-19 and liver injury is unclear. This article describes liver injury induced by COVID-19, analyzes its causes, and discusses the treatment and prognosis of liver damage in patients with COVID-19.
摘要
自2019年12月中国武汉首次报告新型冠状病毒肺炎（COVID-19）以来，该疾病的疫情目前仍在不断演变。先前的研究表明，COVID-19患者存在不同程度的肝损伤。然而，肝损伤的确切原因以及COVID-19与肝损伤之间的关系尚不清楚。本文描述了COVID-19所致的肝损伤，分析了其病因，并探讨了COVID-19患者肝损伤的治疗及预后。
相似文献
1
Liver injury in COVID-19: Known and unknown.
World J Clin Cases. 2021 Jul 6;9(19):4980-4989. doi: 10.12998/wjcc.v9.i19.4980.
2
Liver injury in COVID-19: A minireview.
World J Clin Cases. 2020 Oct 6;8(19):4303-4310. doi: 10.12998/wjcc.v8.i19.4303.
3
[Novel coronavirus pneumonia-related liver injury: etiological analysis and treatment strategy].
Zhonghua Gan Zang Bing Za Zhi. 2020 Feb 20;28(2):97-99. doi: 10.3760/cma.j.issn.1007-3418.2020.02.001.
4
The liver injury and gastrointestinal symptoms in patients with Coronavirus Disease 19: A systematic review and meta-analysis.
Clin Res Hepatol Gastroenterol. 2020 Oct;44(5):653-661. doi: 10.1016/j.clinre.2020.04.012. Epub 2020 May 12.
5
A Review of Acute Myocardial Injury in Coronavirus Disease 2019.
Cureus. 2020 Jun 3;12(6):e8426. doi: 10.7759/cureus.8426.
6
SARS-CoV-2 and COVID-19: How much do we know?
Acta Virol. 2020;64(3):288-296. doi: 10.4149/av_2020_301.
7
[Diagnostic consideration and bedside estimation of the prognosis in COVID-19 patients].
Orv Hetil. 2020 Apr 1;161(17):667-671. doi: 10.1556/650.2020.31815.
8
Coronavirus Disease 2019: Coronaviruses and Kidney Injury.
J Urol. 2020 Nov;204(5):918-925. doi: 10.1097/JU.0000000000001289. Epub 2020 Jul 17.
9
Acute Liver Failure in a COVID-19 Patient Without any Preexisting Liver Disease.
Cureus. 2020 Aug 26;12(8):e10045. doi: 10.7759/cureus.10045.
10
Novel coronavirus disease 2019 (COVID-19) and neurodegenerative disorders.
Dermatol Ther. 2020 Jul;33(4):e13591. doi: 10.1111/dth.13591. Epub 2020 May 26.
引用本文的文献
1
Insight into COVID-19 associated liver injury: Mechanisms, evaluation, and clinical implications.
Hepatol Forum. 2024 Jul 2;5(3):139-149. doi: 10.14744/hf.2023.2023.0025. eCollection 2024.
2
The Role of APRI, FIB-4, and SAD-60 Scores as Predictors of Mortality in COVID-19 Patients.
Infect Dis Clin Microbiol. 2023 Jun 23;5(2):144-152. doi: 10.36519/idcm.2023.233. eCollection 2023 Jun.
3
NASH/NAFLD-Related Hepatocellular Carcinoma: An Added Burden.
Life (Basel). 2023 Dec 23;14(1):25. doi: 10.3390/life14010025.
4
Investigating Acute Hepatitis after SARS-CoV-2 Vaccination or Infection: A Genetic Case Series.
Biomedicines. 2023 Oct 20;11(10):2848. doi: 10.3390/biomedicines11102848.
5
Evaluation of Curcumin-Piperine Supplementation in COVID-19 Patients Admitted to the Intensive Care: A Double-Blind, Randomized Controlled Trial.
Adv Exp Med Biol. 2023;1412:413-426. doi: 10.1007/978-3-031-28012-2_22.
6
Impact of SARS-CoV-2 infection on liver disease.
Adv Lab Med. 2022 Jun 2;3(2):126-141. doi: 10.1515/almed-2022-0037. eCollection 2022 Jun.
7
Liver manifestations in COVID-19 patients: A review article.
World J Clin Cases. 2023 Apr 6;11(10):2189-2200. doi: 10.12998/wjcc.v11.i10.2189.
8
Choosing a cellular model to study SARS-CoV-2.
Front Cell Infect Microbiol. 2022 Oct 21;12:1003608. doi: 10.3389/fcimb.2022.1003608. eCollection 2022.
本文引用的文献
1
Liver Injury as a Surrogate for Inflammation and Predictor of Outcomes in COVID-19.
Hepatol Commun. 2020 Oct 6;5(1):24-32. doi: 10.1002/hep4.1586. eCollection 2021 Jan.
2
COVID-19 prognosis: what we know of the significance and prognostic value of liver-related laboratory parameters in SARS-CoV-2 infection.
Gastroenterol Hepatol Bed Bench. 2020 Fall;13(4):313-320.
3
Liver Injury in Patients Hospitalized with Coronavirus Disease 2019 Correlates with Hyperinflammatory Response and Elevated Interleukin-6.
Hepatol Commun. 2020 Dec 10;5(2):177-188. doi: 10.1002/hep4.1631. eCollection 2021 Feb.
4
Patients with SARS-CoV-2 and HBV co-infection are at risk of greater liver injury.
Genes Dis. 2021 Jul;8(4):484-492. doi: 10.1016/j.gendis.2020.11.005. Epub 2020 Nov 18.
5
Multicenter Analysis of Liver Injury Patterns and Mortality in COVID-19.
Front Med (Lausanne). 2020 Oct 20;7:584342. doi: 10.3389/fmed.2020.584342. eCollection 2020.
6
Clinical characteristics of asymptomatic carriers of novel coronavirus disease 2019: A multi-center study in Jiangsu Province.
Virulence. 2020 Dec;11(1):1557-1568. doi: 10.1080/21505594.2020.1840122.
7
Inflammatory cytokines, T lymphocyte subsets, and ritonavir involved in liver injury of COVID-19 patients.
Signal Transduct Target Ther. 2020 Oct 31;5(1):255. doi: 10.1038/s41392-020-00363-9.
8
Liver Dysfunction and Its Association with the Risk of Death in COVID-19 Patients: A Prospective Cohort Study.
J Clin Transl Hepatol. 2020 Sep 28;8(3):246-254. doi: 10.14218/JCTH.2020.00043. Epub 2020 Aug 20.
9
Descriptive, Retrospective Study of the Clinical Characteristics of Asymptomatic COVID-19 Patients.
mSphere. 2020 Oct 7;5(5):e00922-20. doi: 10.1128/mSphere.00922-20.
10
Clinical characteristics and risk factors of liver injury in COVID-19: a retrospective cohort study from Wuhan, China.
Hepatol Int. 2020 Sep;14(5):723-732. doi: 10.1007/s12072-020-10075-5. Epub 2020 Oct 7.
Zotero 插件